Total Payments
$10,414
2024 Payments
$122.40
Companies
34
Transactions
188
Payment Breakdown by Category
Research$7,094 (68.1%)
Food & Beverage$3,301 (31.7%)
Other$19.37 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7,094 | 2 | 68.1% |
| Food and Beverage | $3,301 | 185 | 31.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19.37 | 1 | 0.2% |
Payments by Type
Research
$7,094
2 transactions
General
$3,320
186 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $7,094 | 2 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $344.66 | 33 | $0 (2020) |
| Medtronic USA, Inc. | $309.45 | 5 | $0 (2018) |
| ACADIA Pharmaceuticals Inc | $232.88 | 7 | $0 (2024) |
| Allergan, Inc. | $194.86 | 19 | $0 (2020) |
| UCB, Inc. | $174.30 | 14 | $0 (2018) |
| GENZYME CORPORATION | $159.90 | 6 | $0 (2018) |
| EMD Serono, Inc. | $154.93 | 10 | $0 (2023) |
| Promius Pharma LLC | $148.82 | 11 | $0 (2018) |
| Avanir Pharmaceuticals, Inc. | $147.88 | 12 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $122.40 | 2 | ACADIA Pharmaceuticals Inc ($122.40) |
| 2023 | $6,907 | 3 | Eli Lilly and Company ($6,864) |
| 2022 | $269.64 | 2 | Eli Lilly and Company ($230.00) |
| 2021 | $31.25 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($31.25) |
| 2020 | $69.95 | 3 | Sunovion Pharmaceuticals Inc. ($42.77) |
| 2019 | $64.75 | 4 | Sunovion Pharmaceuticals Inc. ($64.75) |
| 2018 | $674.15 | 44 | Teva Pharmaceuticals USA, Inc. ($109.36) |
| 2017 | $2,275 | 129 | Medtronic USA, Inc. ($296.99) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $82.93 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/24/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $39.47 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/07/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 04/21/2023 | Eli Lilly and Company | — | — | Cash or cash equivalent | $6,864.00 | Research |
| Study: A PHASE 4 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF GALCANEZUMAB VERSUS RIMEGEPANT IN ADULT PARTICIPANTS WITH EPISODIC MIGRAINE | ||||||
| 04/21/2023 | EMD Serono, Inc. | BAVENCIO (Drug) | Food and Beverage | Cash or cash equivalent | $29.88 | General |
| Category: Oncology | ||||||
| 11/28/2022 | Boston Scientific Corporation | General - Pain Management (Device) | Food and Beverage | In-kind items and services | $39.64 | General |
| Category: General - Pain Management_NMD | ||||||
| 08/04/2022 | Eli Lilly and Company | — | — | In-kind items and services | $230.00 | Research |
| Study: A PHASE 4, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF GALCANEZUMAB VERSUS RIMEGEPANT IN ADULT PARTICIPANTS WITH EPISODIC MIGRAINE | ||||||
| 02/10/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: DIABETES | ||||||
| 10/06/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/13/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: CNS | ||||||
| 02/13/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: CNS | ||||||
| 10/17/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: CNS | ||||||
| 06/10/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: CNS | ||||||
| 03/08/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: CNS | ||||||
| 02/20/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: CNS | ||||||
| 07/30/2018 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/25/2018 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $1.56 | General |
| Category: CNS | ||||||
| 05/10/2018 | GENZYME CORPORATION | LEMTRADA (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 05/01/2018 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Immunology | ||||||
| 04/26/2018 | Upsher-Smith Laboratories LLC | QUDEXY XR Topiramate Extended Release Capsules (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: Neurology | ||||||
| 04/26/2018 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Central Nervous System | ||||||
| 04/25/2018 | AbbVie, Inc. | Duopa (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Neuroscience | ||||||
| 04/19/2018 | EMD Serono, Inc. | Rebif (Biological) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Neurology | ||||||
| 04/18/2018 | GENZYME CORPORATION | LEMTRADA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 04/18/2018 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: CNS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 4 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF GALCANEZUMAB VERSUS RIMEGEPANT IN ADULT PARTICIPANTS WITH EPISODIC MIGRAINE | Eli Lilly and Company | $6,864 | 1 |
| A PHASE 4, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF GALCANEZUMAB VERSUS RIMEGEPANT IN ADULT PARTICIPANTS WITH EPISODIC MIGRAINE | Eli Lilly and Company | $230.00 | 1 |
About Dr. Mildred Dejesus, MD
Dr. Mildred Dejesus, MD is a Neurology healthcare provider based in Gilbert, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376502146.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mildred Dejesus, MD has received a total of $10,414 in payments from pharmaceutical and medical device companies, with $122.40 received in 2024. These payments were reported across 188 transactions from 34 companies. The most common payment nature is "" ($7,094).
Ad
Practice Information
- Specialty Neurology
- Location Gilbert, AZ
- Active Since 03/21/2006
- Last Updated 11/15/2013
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376502146
Products in Payments
- APTIOM (Drug) $344.66
- ACTIVA (Device) $309.45
- NUPLAZID (Drug) $232.88
- Zembrace (Drug) $148.82
- Gamunex-C (Biological) $134.93
- GILENYA (Drug) $133.15
- ACTHAR (Biological) $129.58
- NAMZARIC (Drug) $128.62
- AMYVID (Drug) $126.51
- FARXIGA (Drug) $125.00
- ONZETRA Xsail (Drug) $116.74
- Rebif (Biological) $113.29
- Briviact (Drug) $112.73
- AUBAGIO (Drug) $108.50
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $95.69
- AUSTEDO (Drug) $87.13
- RYTARY (Drug) $75.66
- Neupro (Drug) $61.57
- TREXIMET (Drug) $59.35
- LEMTRADA (Drug) $51.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Gilbert
William Grainger, Md, MD
Neurology — Payments: $442,194
Neurology $442,194
Jonathan Hodgson, Do, DO
Neurology — Payments: $366,071
Neurology $366,071
Paarth Shah, M.d, M.D
Neurology — Payments: $238,823
Neurology $238,823
Kan Yu, Md,Phd, MD,PHD
Neurology — Payments: $39,149
Neurology $39,149
Brian Beck, Md, MD
Neurology — Payments: $17,029
Neurology $17,029
Virgilio Salanga, Md, MD
Neurology — Payments: $1,516
Neurology $1,516